Similarly, in ovarian cancer specimens, the expression of COL11A1 is the highest in recurrent tumors compared to primary and metastatic tumors, suggesting that COL11A1 promotes tumor recurrence post chemotherapy (28–30). The gene discussed is COL11A1; the disease is neoplasm.